218 related articles for article (PubMed ID: 24490447)
1. Role of mucolytics in wet cough.
Dhar R
J Assoc Physicians India; 2013 May; 61(5 Suppl):23-7. PubMed ID: 24490447
[No Abstract] [Full Text] [Related]
2. Can Robitussin DM be used to treat cough during pregnancy?
Ward KE
Med Health R I; 2005 Mar; 88(3):99-100. PubMed ID: 15915786
[No Abstract] [Full Text] [Related]
3. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
4. Clinical trial with terbutaline and guajacol.
Brechter C
Scand J Respir Dis; 1973; 54(2):78-82. PubMed ID: 4575040
[No Abstract] [Full Text] [Related]
5. Rational use of mucoactive medications to treat pediatric airway disease.
Linssen RSN; Ma J; Bem RA; Rubin BK
Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment in bronchial asthma.
Blumstein CG
Semin Drug Treat; 1973; 2(4):385-401. PubMed ID: 4581867
[No Abstract] [Full Text] [Related]
7. Clinical efficacy of farcosolvin syrup (ambroxol-theophylline-guaiphenesin mixture) in the treatment of acute exacerbation of chronic bronchitis.
Yakoot M; Salem A; Omar AM
Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():251-6. PubMed ID: 20714379
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic activity of an association of a mucolytic drug and a bronchodilator agent in the treatment of respiratory inflammations].
Boselli G
Minerva Med; 1973 Nov; 64(79):4128-37. PubMed ID: 4765427
[No Abstract] [Full Text] [Related]
9. [New cholinergic drugs in asthma and COPD].
Kuś J
Pneumonol Alergol Pol; 2002; 70 Suppl 1():61-3. PubMed ID: 12518641
[No Abstract] [Full Text] [Related]
10. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2006 Jun; (15):2077-100. PubMed ID: 16973079
[No Abstract] [Full Text] [Related]
11. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; Ten Hacken N
Clin Evid; 2004 Jun; (11):2003-30. PubMed ID: 15652094
[No Abstract] [Full Text] [Related]
12. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D
Clin Evid; 2003 Jun; (9):1645-63. PubMed ID: 12967439
[No Abstract] [Full Text] [Related]
13. Chronic obstructive pulmonary disease. Part two--management.
Booker R
Nurs Times; 2007 May 1-7; 103(18):28-9. PubMed ID: 17508660
[TBL] [Abstract][Full Text] [Related]
14. [The new COPD guidelines reviewed. Smoking cessation--and what else?].
Wepner U
MMW Fortschr Med; 2003 Feb; 145(8):6-8. PubMed ID: 12661433
[No Abstract] [Full Text] [Related]
15. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
16. Medications for COPD: a review of effectiveness.
Grimes GC; Manning JL; Patel P; Via RM
Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
[TBL] [Abstract][Full Text] [Related]
17. Choice of bronchodilator therapy for patients with COPD.
Wedzicha JA
N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773
[No Abstract] [Full Text] [Related]
18. [Clinical study of ucb 3983 in pediatric (author's transl)].
Goffart P
Acta Paediatr Belg; 1973; 27(4):257-62. PubMed ID: 4358847
[No Abstract] [Full Text] [Related]
19. [How risky are beta-2 mimetics?].
Paukstadt W
MMW Fortschr Med; 2006 Aug; 148(33-34):10. PubMed ID: 16981376
[No Abstract] [Full Text] [Related]
20. The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
Icard BL; Rubio E
Expert Rev Respir Med; 2017 Oct; 11(10):807-814. PubMed ID: 28737047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
